Long Y. Qian

No.678, Furong Road
Hefei, 230601, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus.

Gut microbiota dysbiosis and plasma lipidomic signatures in systemic lupus erythematosus.

Journal: Lupus

Published: August 13, 2026

CST1 suppresses ferroptosis and restricts CD8+ T-cell infiltration and effector function in lung adenocarcinoma via activation of the WNT/β-catenin signaling pathway.

CST1 suppresses ferroptosis and restricts CD8+ T-cell infiltration and effector function in lung adenocarcinoma via activation of the WNT/β-catenin signaling pathway.

Journal: Cellular signalling

Published: May 08, 2026

Insulin resistance-related surrogate indices and recurrence of mild hypertriglyceridemic acute pancreatitis: a retrospective cohort study.

Insulin resistance-related surrogate indices and recurrence of mild hypertriglyceridemic acute pancreatitis: a retrospective cohort study.

Journal: Frontiers in nutrition

Published: May 08, 2026

Effect of lymph node dissection numbers after conversion immunochemotherapy on the survival of gastric cancer patients: a multi-center retrospective study.

Effect of lymph node dissection numbers after conversion immunochemotherapy on the survival of gastric cancer patients: a multi-center retrospective study.

Journal: Frontiers in immunology

Published: April 22, 2026

Clinical Analysis of Gasless Single-Channel Laparoscopic Cholecystectomy for Elderly Patients With Cholecystolithiasis: Retrospective Comparative Cohort Study.

Clinical Analysis of Gasless Single-Channel Laparoscopic Cholecystectomy for Elderly Patients With Cholecystolithiasis: Retrospective Comparative Cohort Study.

Journal: Surgical innovation

Published: April 04, 2026

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial.

Journal: Advances in therapy

Published: February 13, 2026

Targeting galactose metabolic reprogramming overcomes immunotherapy resistance in KRAS-mutant lung adenocarcinoma: Integrative multi-omics and machine learning approaches.

Targeting galactose metabolic reprogramming overcomes immunotherapy resistance in KRAS-mutant lung adenocarcinoma: Integrative multi-omics and machine learning approaches.

Journal: Translational oncology

Published: February 01, 2026

Comprehensive analysis based on tertiary lymphoid structures and tumor budding predicts survival rates in colorectal cancer patients with synchronous liver metastases.

Comprehensive analysis based on tertiary lymphoid structures and tumor budding predicts survival rates in colorectal cancer patients with synchronous liver metastases.

Journal: Frontiers in immunology

Published: December 27, 2025

Metabolic reprogramming-associated genomic instability drives colorectal cancer progression via the UBXN1-NF-κB axis.

Metabolic reprogramming-associated genomic instability drives colorectal cancer progression via the UBXN1-NF-κB axis.

Journal: American journal of translational research

Published: December 25, 2025

Effects of total intravenous anesthesia on postoperative quality of recovery and the levels of inflammatory factors in patients undergoing retroperitoneal endoscopic surgery in urology: Study protocol for a randomized, controlled trial.

Effects of total intravenous anesthesia on postoperative quality of recovery and the levels of inflammatory factors in patients undergoing retroperitoneal endoscopic surgery in urology: Study protocol for a randomized, controlled trial.

Journal: PloS one

Published: December 14, 2025

Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson's disease.

Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: December 06, 2025

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: October 28, 2025

Showing 1-12 of 113

Last Updated: 09/26/2026